Why the study?
Intracellular Ca2+ dysregulation is involved in cardiac hypertrophy, but the precise mechanism remains elusive.
Does enhancing the binding affinity of calmodulin to RyR2 inhibit pressure-overload induced hypertrophic signaling and improve survival?
Does enhancing the binding affinity of calmodulin to RyR2 inhibit pressure-overload induced hypertrophic signaling and improve survival?
Enhancing calmodulin binding to RyR2 prevents pressure-overload induced cardiac hypertrophy and improves survival in a preclinical model, highlighting RyR2 destabilization as a key mechanism.
Cardiac hypertrophy is a well-known major risk factor for poor prognosis in patients with cardiovascular diseases. Dysregulation of intracellular Ca²⁺ is involved in the pathogenesis of cardiac hypertrophy. However, the precise mechanism underlying cardiac hypertrophy remains elusive. Here, we investigate whether pressure-overload induced hypertrophy can be induced by destabilization of cardiac ryanodine receptor (RyR2) through calmodulin (CaM) dissociation and subsequent Ca²⁺ leakage, and whether it can be genetically rescued by enhancing the binding affinity of CaM to RyR2. In the very initial phase of pressure-overload induced cardiac hypertrophy, when cardiac contractile function is preserved, reactive oxygen species (ROS)-mediated RyR2 destabilization already occurs in association with relaxation dysfunction. Further, stabilizing RyR2 by enhancing the binding affinity of CaM to RyR2 completely inhibits hypertrophic signaling and improves survival. Our study uncovers a critical missing link between RyR2 destabilization and cardiac hypertrophy.
No takes yet. Share an insight, caveat, or question.
Kohno et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: